DCGI approves study at CMC Vellore to test efficacy of mixing doses of Covaxin and Covishield vaccines
CMC Vellore will conduct a study and clinical trial to determine if a person can take two different vaccine shots of Covidshield and Covaxin to complete the vaccination course.
From reports of shortages to black-marketing, is Remdesivir really the ‘miracle drug’ to cure Covid?
In November 2020, World Health Organization (WHO) recommended against the use of Remdesivir in Covid-19 patients stating that there was no evidence that the drug can improve survival.
The phase 3 trials involved 25,800 subjects. The trial, done in collaboration with ICMR, is the largest ever clinical trial done in India.
DCGI had asked Serum Institute why it had not informed them about AstraZeneca halting its trials in other countries.
Health Ministry cautions on use of plasma therapy for coronavirus, says it can be harmful as still being tested
The USFDA had also said that the plasma therapy has not yet been proven to be safe and efficient treatment for Chinese Coronavirus.